首页 > 最新文献

Journal of Global Infectious Diseases最新文献

英文 中文
SARS-CoV-2 and Legionella Co-Infection. SARS-CoV-2和军团菌共感染。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.4103/jgid.jgid_92_22
Caitlin A Gauvin, Barbara Mian, George Psevdos, Audun J Lier
The COVID-19 pandemic has caused a historic public health emergency, with an estimated 458 million confirmed cases and 6 million deaths.[1] The highly transmissible SARS-CoV-2 virus can cause severe pneumonia as well as extrapulmonary sequelae, making accurate diagnosis and management crucial.[2] Legionnaire’s disease is a severe atypical bacterial pneumonia that can be associated with SARS-CoV-2 infection.[3] Like SARS-CoV-2 infection, legionella may be associated with extrapulmonary symptoms, including diarrhea, hyponatremia, and neurological manifestations such as encephalopathy, among others.[4] Importantly, the mortality rate of legionella infection is high, with one study reporting over 6% mortality despite appropriate antibiotic therapy with either azithromycin or a fluoroquinolone.[5]
{"title":"SARS-CoV-2 and Legionella Co-Infection.","authors":"Caitlin A Gauvin, Barbara Mian, George Psevdos, Audun J Lier","doi":"10.4103/jgid.jgid_92_22","DOIUrl":"https://doi.org/10.4103/jgid.jgid_92_22","url":null,"abstract":"The COVID-19 pandemic has caused a historic public health emergency, with an estimated 458 million confirmed cases and 6 million deaths.[1] The highly transmissible SARS-CoV-2 virus can cause severe pneumonia as well as extrapulmonary sequelae, making accurate diagnosis and management crucial.[2] Legionnaire’s disease is a severe atypical bacterial pneumonia that can be associated with SARS-CoV-2 infection.[3] Like SARS-CoV-2 infection, legionella may be associated with extrapulmonary symptoms, including diarrhea, hyponatremia, and neurological manifestations such as encephalopathy, among others.[4] Importantly, the mortality rate of legionella infection is high, with one study reporting over 6% mortality despite appropriate antibiotic therapy with either azithromycin or a fluoroquinolone.[5]","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"15 1","pages":"40"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cf/2e/JGID-15-40.PMC10118213.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Erysipelothrix Bacteremia; is Endocarditis a Rule? Erysipelothrix菌血症;心内膜炎是常见病吗?
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.4103/jgid.jgid_30_22
Haripriya Reddy Challa, Ashwini Choudary Tayade, Srimathy Venkatesh, P Senthur Nambi

Erysipelothrix rhusiopathiae is a Gram-positive bacillus, a zoonotic pathogen rarely causing human infections ranging from localized skin infections to invasive infections such as endocarditis. In this report, we present two cases of Erysipelothrix bacteremia. The first case is a native valve tricuspid endocarditis, which is a highly unusual valve to be involved. The second case is bacteremia, probably secondary to a minor skin breach, which did not involve heart valves. Erysipelothrix bacteremia is considered highly associated with infective endocarditis and a high mortality rate, which could be a bias due to underreporting of Erysipelothrix bacteremia without endocarditis. Erysipelothrix is intrinsically resistant to vancomycin, the first-line agent for Gram-positive bacteremia. Both the patients in this report were treated successfully with ceftriaxone.

红唇丹毒是一种革兰氏阳性杆菌,是一种很少引起人类感染的人畜共患病原体,范围从局部皮肤感染到心内膜炎等侵袭性感染。在本报告中,我们提出了两例丹毒杆菌菌血症。第一个病例是先天性瓣膜三尖瓣心内膜炎,这是一种非常罕见的瓣膜受累。第二个病例是菌血症,可能继发于轻微的皮肤破裂,不涉及心脏瓣膜。丹毒杆菌血症被认为与感染性心内膜炎和高死亡率高度相关,这可能是一种偏差,因为没有心内膜炎的丹毒杆菌血症报告不足。丹毒弧菌对万古霉素具有内在耐药性,万古霉素是治疗革兰氏阳性菌血症的一线药物。本报告的两例患者均成功使用头孢曲松治疗。
{"title":"<i>Erysipelothrix</i> Bacteremia; is Endocarditis a Rule?","authors":"Haripriya Reddy Challa,&nbsp;Ashwini Choudary Tayade,&nbsp;Srimathy Venkatesh,&nbsp;P Senthur Nambi","doi":"10.4103/jgid.jgid_30_22","DOIUrl":"https://doi.org/10.4103/jgid.jgid_30_22","url":null,"abstract":"<p><p><i>Erysipelothrix rhusiopathiae</i> is a Gram-positive bacillus, a zoonotic pathogen rarely causing human infections ranging from localized skin infections to invasive infections such as endocarditis. In this report, we present two cases of <i>Erysipelothrix</i> bacteremia. The first case is a native valve tricuspid endocarditis, which is a highly unusual valve to be involved. The second case is bacteremia, probably secondary to a minor skin breach, which did not involve heart valves. <i>Erysipelothrix</i> bacteremia is considered highly associated with infective endocarditis and a high mortality rate, which could be a bias due to underreporting of <i>Erysipelothrix</i> bacteremia without endocarditis. <i>Erysipelothrix</i> is intrinsically resistant to vancomycin, the first-line agent for Gram-positive bacteremia. Both the patients in this report were treated successfully with ceftriaxone.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"15 1","pages":"31-34"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/57/9b/JGID-15-31.PMC10118208.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9444330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ruptured Pulmonary Hydatid Cyst. 肺包虫囊肿破裂。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.4103/jgid.jgid_137_22
Ananda Datta, Srikanth M Goud, Prasanta Raghab Mohapatra

A 37-year-old male presented with left-sided hydropneumothorax. After drainage of fluid and air from the pleural cavity, chest radiograph and computed tomography of chest showed characteristic radiological image of ruptured hydatid cyst. The diagnosis was supported by positive echinococcal serology.

一名37岁男性,表现为左侧气胸积液。胸膜腔引流液气后,胸片及胸部计算机断层扫描显示包虫囊肿破裂的特征性影像学表现。棘球蚴血清学阳性支持诊断。
{"title":"Ruptured Pulmonary Hydatid Cyst.","authors":"Ananda Datta,&nbsp;Srikanth M Goud,&nbsp;Prasanta Raghab Mohapatra","doi":"10.4103/jgid.jgid_137_22","DOIUrl":"https://doi.org/10.4103/jgid.jgid_137_22","url":null,"abstract":"<p><p>A 37-year-old male presented with left-sided hydropneumothorax. After drainage of fluid and air from the pleural cavity, chest radiograph and computed tomography of chest showed characteristic radiological image of ruptured hydatid cyst. The diagnosis was supported by positive echinococcal serology.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"15 1","pages":"35-36"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bb/4c/JGID-15-35.PMC10118214.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741112","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Waning of Antibody Response Among Vaccinees who Received Two Doses of Covishield Vaccine. 接种两剂Covishield疫苗的人抗体反应减弱。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.4103/jgid.jgid_128_22
Shivani Haritay, Rithia Patil, Arif Maldar, Anil Kumar, Vikrama Reddy, Deshna Oswal, Masood Ahmed Tahashildar, Akshay Kolakar, Satish Kabbur, Jang Bahadur Prasad, M S Shivaswamy, Ramesh Paranjape, Mubashir Angolkar

Introduction: There are limited data available on the long-term presence of SARS-CoV-2-specific binding antibodies and neutralizing antibodies in circulation among the elderly population. This study aims to examine levels of anti-SARS-CoV-2 antibodies in vaccines who have completed at least 6 months since the second vaccine dose. A cross-sectional study was conducted from November 2021 to January 2022 among 199 vaccines aged 60 years and above residing in Belagavi city, who received two doses of the Covishield vaccine.

Methods: Antibody response to SARS-COV-2 virus whole cell antigen was measured by a kit COVID KAWACH IgG Micro LISA (J Mitra and Company, India) in 199 participants who had completed at least 6 months after receiving the second dose of Covishield vaccine. The antibody response was measured as a ratio of optical density (OD) in the participant's sample to the mean OD in negative control test by normal (T/N). Independent Kruskal-Wallis test was applied to test the difference between the T/N ratio by months of vaccination since the second dose and by the age group strata.

Results: The median T/N values among participants who completed 6, 7, 8, and 9 months since the second vaccine dose were 14.17, 10.46, 7.93, and 5.11, respectively, and this decline in T/N values was statistically significant. Antibody response values showed a decline with increasing age for participants in the age strata 60-69, 70-79, and 80 and above, respectively.

Conclusions: A significant decline was observed in antibody response over 9 months supporting the administration of booster dose of vaccine.

关于老年人血液循环中长期存在sars - cov -2特异性结合抗体和中和抗体的数据有限。本研究旨在检测自第二剂疫苗接种后至少6个月的疫苗中抗sars - cov -2抗体的水平。从2021年11月至2022年1月,对居住在贝拉加维市的199名60岁及以上的疫苗接种者进行了一项横断面研究,他们接种了两剂Covishield疫苗。方法:采用COVID KAWACH IgG Micro LISA试剂盒(J Mitra and Company, India)检测199例接种第二剂Covishield疫苗后至少6个月的受试者对SARS-COV-2病毒全细胞抗原的抗体反应。抗体反应以参与者样本的光密度(OD)与阴性对照试验中平均OD的比值(T/N)来衡量。采用独立的Kruskal-Wallis试验来检测自第二次接种以来接种的月份和年龄组层之间的T/N比率的差异。结果:接种第二次疫苗后6、7、8和9个月的参与者中位T/N值分别为14.17、10.46、7.93和5.11,T/N值的下降具有统计学意义。抗体应答值在60-69岁、70-79岁和80岁及以上年龄段分别随着年龄的增加而下降。结论:9个月后,支持接种加强剂疫苗的抗体应答显著下降。
{"title":"Waning of Antibody Response Among Vaccinees who Received Two Doses of Covishield Vaccine.","authors":"Shivani Haritay,&nbsp;Rithia Patil,&nbsp;Arif Maldar,&nbsp;Anil Kumar,&nbsp;Vikrama Reddy,&nbsp;Deshna Oswal,&nbsp;Masood Ahmed Tahashildar,&nbsp;Akshay Kolakar,&nbsp;Satish Kabbur,&nbsp;Jang Bahadur Prasad,&nbsp;M S Shivaswamy,&nbsp;Ramesh Paranjape,&nbsp;Mubashir Angolkar","doi":"10.4103/jgid.jgid_128_22","DOIUrl":"https://doi.org/10.4103/jgid.jgid_128_22","url":null,"abstract":"<p><strong>Introduction: </strong>There are limited data available on the long-term presence of SARS-CoV-2-specific binding antibodies and neutralizing antibodies in circulation among the elderly population. This study aims to examine levels of anti-SARS-CoV-2 antibodies in vaccines who have completed at least 6 months since the second vaccine dose. A cross-sectional study was conducted from November 2021 to January 2022 among 199 vaccines aged 60 years and above residing in Belagavi city, who received two doses of the Covishield vaccine.</p><p><strong>Methods: </strong>Antibody response to SARS-COV-2 virus whole cell antigen was measured by a kit COVID KAWACH IgG Micro LISA (J Mitra and Company, India) in 199 participants who had completed at least 6 months after receiving the second dose of Covishield vaccine. The antibody response was measured as a ratio of optical density (OD) in the participant's sample to the mean OD in negative control test by normal (T/N). Independent Kruskal-Wallis test was applied to test the difference between the T/N ratio by months of vaccination since the second dose and by the age group strata.</p><p><strong>Results: </strong>The median T/N values among participants who completed 6, 7, 8, and 9 months since the second vaccine dose were 14.17, 10.46, 7.93, and 5.11, respectively, and this decline in T/N values was statistically significant. Antibody response values showed a decline with increasing age for participants in the age strata 60-69, 70-79, and 80 and above, respectively.</p><p><strong>Conclusions: </strong>A significant decline was observed in antibody response over 9 months supporting the administration of booster dose of vaccine.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"15 1","pages":"19-22"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e4/89/JGID-15-19.PMC10118211.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neonatal Meningitis Secondary to Elizabethkingia meningoseptica Infection. 新生儿脑膜炎继发于伊莉莎白脑膜炎败血症感染。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.4103/jgid.jgid_111_22
Srishti Goel, Sandeep Dayanand Jhajra, Sushma Nangia, Ajay Kumar, Debasish Nanda

Introduction: Elizabethkingia meningoseptica, a rare cause of sepsis and meningitis in neonates, often associated with a wide spectrum of clinical presentation. The objective of the study was to describe the clinical characteristics and outcome of neonates, who developed meningitis secondary to Elizabethkingia meningoseptica infection at a tertiary care Neonatal unit in India.

Methods: This retrospective study was conducted in the neonatal unit of a tertiary care hospital in New Delhi. The clinical data including demographic data, clinical presentation, management, and outcome data were collected and analyzed.

Results: During the study, 7 neonates with meningitis secondary to Elizabethkingia infection were identified. Majority of the neonates were preterm with a median gestational age of 31 (interquartile range: 29-33.5) weeks and a median birth weight of 1250 g (interquartile range: 1024-2065). The median age of onset of symptoms was 7 days. Lethargy (100%), apnea (85%), seizure (71%), and feeding difficulties (42%) were the common clinical presentations. Overall mortality during the period was 28.5%, and 60% of the survivor developed hydrocephalus. Isolated strains were resistant to the commonly used antibiotics (piperacillin-tazobactam, aminoglycosides, meropenem, and colistin) effective against Gram-negative organisms. The environmental screening was done but the potential source of infection could not be identified conclusively.

Conclusion: Meningitis in neonates caused by Elizabethkingia represents a potentially life-threatening infection and is often associated with significant neurological impairment, especially in premature neonates. A prolonged duration of antibiotic therapy, longer hospital stay, and likelihood of adverse neurologic sequelae during the hospital stay and follow-up should be anticipated in such cases of meningitis.

简介:伊莉莎白菌脑膜炎败血症,新生儿败血症和脑膜炎的罕见原因,通常与广泛的临床表现相关。该研究的目的是描述在印度三级护理新生儿病房发生伊丽莎白脑膜炎败血症感染继发脑膜炎的新生儿的临床特征和结局。方法:本回顾性研究在新德里一家三级医院的新生儿病房进行。收集和分析临床资料,包括人口统计资料、临床表现、管理和结局资料。结果:本研究共发现7例新生儿感染伊莉莎白菌继发性脑膜炎。大多数新生儿为早产儿,中位胎龄为31周(四分位数范围:29-33.5),中位出生体重为1250克(四分位数范围:1024-2065)。出现症状的中位年龄为7天。嗜睡(100%)、呼吸暂停(85%)、癫痫发作(71%)和进食困难(42%)是常见的临床表现。在此期间,总死亡率为28.5%,60%的幸存者发生脑积水。分离的菌株对常用抗生素(哌拉西林-他唑巴坦、氨基糖苷类、美罗培南和粘菌素)耐药,这些抗生素对革兰氏阴性菌有效。环境筛查虽已完成,但仍无法确定潜在的感染源。结论:伊莉莎白菌引起的新生儿脑膜炎是一种潜在的危及生命的感染,通常与严重的神经损伤有关,尤其是早产儿。在这类脑膜炎病例中,抗生素治疗时间延长,住院时间延长,住院和随访期间出现不良神经系统后遗症的可能性也应予以考虑。
{"title":"Neonatal Meningitis Secondary to <i>Elizabethkingia meningoseptica</i> Infection.","authors":"Srishti Goel,&nbsp;Sandeep Dayanand Jhajra,&nbsp;Sushma Nangia,&nbsp;Ajay Kumar,&nbsp;Debasish Nanda","doi":"10.4103/jgid.jgid_111_22","DOIUrl":"https://doi.org/10.4103/jgid.jgid_111_22","url":null,"abstract":"<p><strong>Introduction: </strong><i>Elizabethkingia meningoseptica</i>, a rare cause of sepsis and meningitis in neonates, often associated with a wide spectrum of clinical presentation. The objective of the study was to describe the clinical characteristics and outcome of neonates, who developed meningitis secondary to <i>Elizabethkingia meningoseptica</i> infection at a tertiary care Neonatal unit in India.</p><p><strong>Methods: </strong>This retrospective study was conducted in the neonatal unit of a tertiary care hospital in New Delhi. The clinical data including demographic data, clinical presentation, management, and outcome data were collected and analyzed.</p><p><strong>Results: </strong>During the study, 7 neonates with meningitis secondary to <i>Elizabethkingia</i> infection were identified. Majority of the neonates were preterm with a median gestational age of 31 (interquartile range: 29-33.5) weeks and a median birth weight of 1250 g (interquartile range: 1024-2065). The median age of onset of symptoms was 7 days. Lethargy (100%), apnea (85%), seizure (71%), and feeding difficulties (42%) were the common clinical presentations. Overall mortality during the period was 28.5%, and 60% of the survivor developed hydrocephalus. Isolated strains were resistant to the commonly used antibiotics (piperacillin-tazobactam, aminoglycosides, meropenem, and colistin) effective against Gram-negative organisms. The environmental screening was done but the potential source of infection could not be identified conclusively.</p><p><strong>Conclusion: </strong>Meningitis in neonates caused by <i>Elizabethkingia</i> represents a potentially life-threatening infection and is often associated with significant neurological impairment, especially in premature neonates. A prolonged duration of antibiotic therapy, longer hospital stay, and likelihood of adverse neurologic sequelae during the hospital stay and follow-up should be anticipated in such cases of meningitis.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"15 1","pages":"23-27"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e3/53/JGID-15-23.PMC10118212.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9443847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Infectious Mononucleosis Presenting as Near-Fatal Tracheal Obstruction. 传染性单核细胞增多症表现为近乎致命的气管阻塞。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.4103/jgid.jgid_38_22
Sunil Kumar, Sanyukta Hepat, Sourya Acharya, Samarth Shukla, Shraddha Jain, Abhijit Wadekar, Gaurav Jagtap, Siva Reddy

Infectious mononucleosis (IM) caused by Epstein-Barr virus is a self-limiting condition and usually carries a benign course. It is usually seen in adolescents and young adults. However, complications can occur in a small percentage of patients such as splenic rupture, myocarditis, and meningitis. Tracheal obstruction as a result of IM is extremely rare. In this case report, we highlighted a rare complication of nearly fatal tracheal obstruction in a young patient of IM that was managed timely by emergency tracheostomy.

由eb病毒引起的传染性单核细胞增多症(IM)是一种自限性疾病,通常具有良性病程。它通常见于青少年和年轻人。然而,也有一小部分患者会出现并发症,如脾破裂、心肌炎和脑膜炎。气管阻塞的结果是非常罕见的。在这个病例报告中,我们强调了一个罕见的并发症,几乎致命的气管阻塞在一个年轻的IM患者是及时处理的紧急气管切开术。
{"title":"Infectious Mononucleosis Presenting as Near-Fatal Tracheal Obstruction.","authors":"Sunil Kumar,&nbsp;Sanyukta Hepat,&nbsp;Sourya Acharya,&nbsp;Samarth Shukla,&nbsp;Shraddha Jain,&nbsp;Abhijit Wadekar,&nbsp;Gaurav Jagtap,&nbsp;Siva Reddy","doi":"10.4103/jgid.jgid_38_22","DOIUrl":"https://doi.org/10.4103/jgid.jgid_38_22","url":null,"abstract":"<p><p>Infectious mononucleosis (IM) caused by Epstein-Barr virus is a self-limiting condition and usually carries a benign course. It is usually seen in adolescents and young adults. However, complications can occur in a small percentage of patients such as splenic rupture, myocarditis, and meningitis. Tracheal obstruction as a result of IM is extremely rare. In this case report, we highlighted a rare complication of nearly fatal tracheal obstruction in a young patient of IM that was managed timely by emergency tracheostomy.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"15 1","pages":"28-30"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d5/73/JGID-15-28.PMC10118205.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9443848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dengue Hemorrhagic Encephalitis in Dengue Epidemic. 登革流行中的登革出血性脑炎。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.4103/jgid.jgid_147_22
Prabhat Kumar Singh, Ankita Sheoran, Pradeep Tetarwal, Pratap Singh, Priyanka Singh
{"title":"Dengue Hemorrhagic Encephalitis in Dengue Epidemic.","authors":"Prabhat Kumar Singh,&nbsp;Ankita Sheoran,&nbsp;Pradeep Tetarwal,&nbsp;Pratap Singh,&nbsp;Priyanka Singh","doi":"10.4103/jgid.jgid_147_22","DOIUrl":"https://doi.org/10.4103/jgid.jgid_147_22","url":null,"abstract":"","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"15 1","pages":"37-38"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6a/4e/JGID-15-37.PMC10118216.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9444325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance of Aerosol Boxes for Endotracheal Intubation during the COVID-19 Pandemic with Systematic Review. 新型冠状病毒肺炎大流行期间气管插管气雾剂盒性能的系统评价
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2023-01-01 DOI: 10.4103/jgid.jgid_165_22
R Ajay Christopher, Aparna Lohanathan, Darpanarayan Hazra, Rathijit Pal, Vaishnavi Vegiraju, Kundavaram Paul Prabhakar Abhilash

Introduction: In the backdrop of the COVID-19 pandemic, endotracheal intubation using an aerosol box (AB) became the norm in the emergency department (ED) and the intensive care unit. We compared two models of AB with different dimensions to compare and identify a device that helps in reducing viral exposure without compromising successful airway management.

Methods: We conducted this prospective observational study for 7 months (October 20-April 21) on 143 patients presenting with an acute airway compromise to the ED. All intubations were performed using one of the two models available. The primary outcome was time taken for intubation (TTI).

Results: The overall median time taken to intubate using any AB was 63 (interquartile range [IQR]: 46.2-87.7) s with an 81.9% first-pass success (FPS) rate. TTI for AB I was 67 (IQR: 53-106) s with a 76.3% FPS rate, while TTI for AB II was 57 (IQR: 44-75) s with an 85.9% FPS rate. TTI was much shorter without the use of an AB (34: IQR: 24-53 s) with a 92% FPS rate. Intubations done by emergency physicians with more than 2 years of experience were faster in both with or without AB when compared to intubations done by physicians with <2 years of experience.

Conclusion: The use of an AB is associated with a longer TTI when compared to intubations done without an AB. TTI was relatively shorter when more experienced emergency physicians performed intubation. FPS rates were low with intubations done using AB.

在2019冠状病毒病大流行的背景下,使用气溶胶盒(AB)进行气管插管已成为急诊科(ED)和重症监护病房的常态。我们比较了两种不同尺寸的AB模型,以比较和确定一种有助于减少病毒暴露而不影响成功气道管理的设备。方法:我们对143例急症患者进行了为期7个月(10月20日至4月21日)的前瞻性观察性研究。所有患者均使用两种可用模型中的一种进行插管。主要观察指标为插管时间(TTI)。结果:使用任何AB插管所需的总中位时间为63(四分位数间距[IQR]: 46.2-87.7) s,首次通过成功率(FPS)为81.9%。AB I的TTI为67 (IQR: 53-106) s, FPS率为76.3%;AB II的TTI为57 (IQR: 44-75) s, FPS率为85.9%。在不使用AB的情况下,TTI要短得多(34:IQR: 24-53秒),FPS率为92%。结论:与没有AB的插管相比,使用AB与TTI时间较长相关。当经验丰富的急诊医生进行插管时,TTI时间相对较短。使用AB插管时,FPS率较低。
{"title":"Performance of Aerosol Boxes for Endotracheal Intubation during the COVID-19 Pandemic with Systematic Review.","authors":"R Ajay Christopher,&nbsp;Aparna Lohanathan,&nbsp;Darpanarayan Hazra,&nbsp;Rathijit Pal,&nbsp;Vaishnavi Vegiraju,&nbsp;Kundavaram Paul Prabhakar Abhilash","doi":"10.4103/jgid.jgid_165_22","DOIUrl":"https://doi.org/10.4103/jgid.jgid_165_22","url":null,"abstract":"<p><strong>Introduction: </strong>In the backdrop of the COVID-19 pandemic, endotracheal intubation using an aerosol box (AB) became the norm in the emergency department (ED) and the intensive care unit. We compared two models of AB with different dimensions to compare and identify a device that helps in reducing viral exposure without compromising successful airway management.</p><p><strong>Methods: </strong>We conducted this prospective observational study for 7 months (October 20-April 21) on 143 patients presenting with an acute airway compromise to the ED. All intubations were performed using one of the two models available. The primary outcome was time taken for intubation (TTI).</p><p><strong>Results: </strong>The overall median time taken to intubate using any AB was 63 (interquartile range [IQR]: 46.2-87.7) s with an 81.9% first-pass success (FPS) rate. TTI for AB I was 67 (IQR: 53-106) s with a 76.3% FPS rate, while TTI for AB II was 57 (IQR: 44-75) s with an 85.9% FPS rate. TTI was much shorter without the use of an AB (34: IQR: 24-53 s) with a 92% FPS rate. Intubations done by emergency physicians with more than 2 years of experience were faster in both with or without AB when compared to intubations done by physicians with <2 years of experience.</p><p><strong>Conclusion: </strong>The use of an AB is associated with a longer TTI when compared to intubations done without an AB. TTI was relatively shorter when more experienced emergency physicians performed intubation. FPS rates were low with intubations done using AB.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"15 1","pages":"6-12"},"PeriodicalIF":1.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/24/41/JGID-15-6.PMC10118207.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Capsule-Deficient Cryptococcal Meningitis: A Diagnostic Conundrum. 缺囊性隐球菌脑膜炎:诊断难题。
IF 1 Q4 INFECTIOUS DISEASES Pub Date : 2022-11-15 eCollection Date: 2022-10-01 DOI: 10.4103/jgid.jgid_255_21
Trupti Shende, Gagandeep Singh, Immaculata Xess, Swati Khullar, Renu Kumari Yadav, Reshu Agarwal, M Vasantha Padma Srivastava

Cryptococcosis is a serious systemic mycosis. Its incidence has escalated in the past four decades. Cryptococcus neoformans causes localized or disseminated infection in immunocompromised and immunocompetent patients. The capsulated form is commonly encountered which can be diagnosed on an India ink preparation or antigen detection. However, the noncapsulated forms are very rare and require a high index of suspicion for correct diagnosis. Herein, we present a case of cryptococcal meningitis due to a noncapsulated strain in an apparently immunocompetent patient with no proven immunodeficiencies along with review of world literature. Such cases are a diagnostic challenge for the clinician as well as microbiologist.

隐球菌病是一种严重的全身性真菌病。在过去 40 年中,其发病率不断上升。新型隐球菌可在免疫力低下和免疫力正常的患者中引起局部感染或播散感染。常见的是荚膜型,可通过印度墨水制剂或抗原检测进行诊断。然而,无囊型非常罕见,需要高度怀疑才能正确诊断。在本文中,我们介绍了一例隐球菌脑膜炎病例,该病例是由一株无囊菌株引起的,患者表面上免疫功能正常,未证实有免疫缺陷。此类病例对临床医生和微生物学家来说都是一个诊断难题。
{"title":"Capsule-Deficient Cryptococcal Meningitis: A Diagnostic Conundrum.","authors":"Trupti Shende, Gagandeep Singh, Immaculata Xess, Swati Khullar, Renu Kumari Yadav, Reshu Agarwal, M Vasantha Padma Srivastava","doi":"10.4103/jgid.jgid_255_21","DOIUrl":"10.4103/jgid.jgid_255_21","url":null,"abstract":"<p><p>Cryptococcosis is a serious systemic mycosis. Its incidence has escalated in the past four decades. <i>Cryptococcus neoformans</i> causes localized or disseminated infection in immunocompromised and immunocompetent patients. The capsulated form is commonly encountered which can be diagnosed on an India ink preparation or antigen detection. However, the noncapsulated forms are very rare and require a high index of suspicion for correct diagnosis. Herein, we present a case of cryptococcal meningitis due to a noncapsulated strain in an apparently immunocompetent patient with no proven immunodeficiencies along with review of world literature. Such cases are a diagnostic challenge for the clinician as well as microbiologist.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"14 4","pages":"165-169"},"PeriodicalIF":1.0,"publicationDate":"2022-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c8/2d/JGID-14-165.PMC9831207.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10528313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delftia acidovorans: An Unusual Pathogen from an Adenocarcinoma Lung Patient with Pleural Effusion. 嗜酸Delftia acidovorans:一例伴有胸腔积液的肺腺癌患者的一种罕见病原体。
IF 1.6 Q4 INFECTIOUS DISEASES Pub Date : 2022-11-01 eCollection Date: 2023-07-01 DOI: 10.4103/jgid.jgid_66_22
Sujata Lall, Vivek Bhat, Sanjay Biswas, Amit Joshi, Amit Janu

Delftia acidovorans (D. acidovorans) is an aerobic, nonfermentative Gram-negative bacillus infrequently isolated from clinical specimens. The pathogenicity and clinical significance of the organism has not been ascertained due to uncommon clinical isolation and suspected low virulence. The organism has been reported to be inherently resistant to aminoglycoside group of drugs which remain as a widely used first-line drug of choice for febrile neutropenic patients. Hereby, we report a case of D. acidovorans-associated pleural effusion in a patient of metastatic adenocarcinoma diagnosed and treated timely and successfully with appropriate antibiotics.

嗜酸Delftia acidovorans是一种需氧、非发酵的革兰氏阴性杆菌,很少从临床标本中分离出来。由于罕见的临床分离和疑似低毒力,该生物体的致病性和临床意义尚未确定。据报道,该生物体对氨基糖苷类药物具有固有耐药性,氨基糖苷类是发热性中性粒细胞减少症患者广泛使用的一线药物。在此,我们报告了一例转移性腺癌患者的嗜酸乳杆菌相关胸腔积液,该患者及时诊断并用适当的抗生素成功治疗。
{"title":"<i>Delftia acidovorans</i>: An Unusual Pathogen from an Adenocarcinoma Lung Patient with Pleural Effusion.","authors":"Sujata Lall,&nbsp;Vivek Bhat,&nbsp;Sanjay Biswas,&nbsp;Amit Joshi,&nbsp;Amit Janu","doi":"10.4103/jgid.jgid_66_22","DOIUrl":"10.4103/jgid.jgid_66_22","url":null,"abstract":"<p><p><i>Delftia acidovorans (D. acidovorans)</i> is an aerobic, nonfermentative Gram-negative bacillus infrequently isolated from clinical specimens. The pathogenicity and clinical significance of the organism has not been ascertained due to uncommon clinical isolation and suspected low virulence. The organism has been reported to be inherently resistant to aminoglycoside group of drugs which remain as a widely used first-line drug of choice for febrile neutropenic patients. Hereby, we report a case of <i>D. acidovorans-</i>associated pleural effusion in a patient of metastatic adenocarcinoma diagnosed and treated timely and successfully with appropriate antibiotics.</p>","PeriodicalId":51581,"journal":{"name":"Journal of Global Infectious Diseases","volume":"15 3","pages":"121-123"},"PeriodicalIF":1.6,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e5/ad/JGID-15-121.PMC10549903.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41173492","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Global Infectious Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1